Molar Incisor Hypomineralization and Hypomineralized Second Primary Molars
Prevalence and Clinical Characteristics of Molar Incisor Hypomineralization (MIH) and Hypomineralized Second Primary Molars (HSPM) Among Italian, Spanish and Turkish Children: a Multicenter Epidemiological Study
1 other identifier
observational
97
3 countries
5
Brief Summary
Molar and Incisor Hypomineralization (MIH) is a qualitative developmental defect of the dental enamel with a multifactorial aetiology defined in 2001 as an "hypomineralization of systemic origin affecting one or more permanent molars, usually first permanent molars (FPMs) with or without the involvement of one or more affected permanent incisors". Due to its porous structure with an altered prism organization and an increased content of proteins, the hypomineralized enamel has reduced mechanical properties and a lower refractive index in comparison to the sound enamel. MIH is associated to a large number of objective and subjective problems as an altered aesthetics, an increased risk of plaque accumulation, caries and/or post-eruptive breakdown, reduced retention rates of adhesive materials, hypersensitivity and difficulty in anesthetizing the affected teeth that make its management a challenging condition. MIH is a very widespread pathology with a worldwide prevalence ranging from 2.8 to 44% and a global average prevalence of 13.1% with significant geographical differences. In 2015, the number of global prevalent cases was estimated at 878 million people with a percentage of needing-care cases of 27.4% (in mean 240 million prevalent cases). In Europe, MIH prevalence rates between 3.6 to 25%. Regarding Italy, a limited number of prevalence studies are available. Recently, literature reports that the presence of MIH-like lesions in primary dentition, especially on second primary molars, may be a predictive factor for developing MIH in permanent dentition. However, the absence of this defect called Hypomineralized Second Primary Molars (HSPM) does not rule out MIH development. The early diagnosis of HSPM is very useful to early diagnose MIH and reduce its care burden. The reported HSPM global prevalence rate ranges from 0 to 21.8% with a global average about 7.88%. MIH and HSPM are both very widespread pathologies affecting an increasing number of children worldwide and represent a significant problem in pediatric dentistry. The aim of this study is to estimate the prevalence of MIH in Italian (Trieste), Spanish (Huesca, Zaragoza) and Turkish (Istanbul) children. The hypothesis is that the estimated prevalence of MIH may be in line with that reported in literature and that the presence of HSPM in primary dentition may be associated with MIH development in permanent dentition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2021
Longer than P75 for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 2, 2021
CompletedFirst Submitted
Initial submission to the registry
March 28, 2023
CompletedFirst Posted
Study publicly available on registry
April 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedMay 16, 2025
May 1, 2025
3.8 years
March 28, 2023
May 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
MIH prevalence rate
Prevalence of the condition in the populations studied
At baseline (day one)
Secondary Outcomes (4)
Description of MIH clinical characteristics
At baseline (day one)
Frequency of the most frequently affected teeth
At baseline (day one)
Association between HSPM and MIH development
At baseline (day one)
Association between MIH/HSPM and presence of caries
At baseline (day one)
Eligibility Criteria
Subjects will be selected among patients attending the involved Dental Clinics according to the following criteria
You may qualify if:
- Age: 6-16 years;
- Signature of the informed consent to the study by patients' parents or by their legal guardians
You may not qualify if:
- Fluorosis, white spots, amelogenesis imperfecta, hypoplasia or other dental enamel defects in differential diagnosis with MIH and HSPM;
- Patients not sufficiently cooperative;
- Children with orthodontic devices hiding the teeth to consider
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
IRCCS Burlo Garofolo
Trieste, Italy, 34137, Italy
Maggiore Hospital
Trieste, Trieste, Italy
IRCCS Burlo Garofolo
Trieste, 34137, Italy
Servicio de Odontología de la Universidad de Zaragoza
Huesca, Huesca, Spain
Faculty of Dentistry of the Yeditepe University
Istanbul, Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Milena Cadenaro, MD
IRCCS materno infantile Burlo Garofolo
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 28, 2023
First Posted
April 12, 2023
Study Start
March 2, 2021
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
May 16, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share